Risultati della ricerca - Cecilia M. Fenoglio‐Preiser

  • Mostra 1 - 10 risultati su 10
Raffina i risultati
  1. 1
    The future of prognostic factors in outcome prediction for patients with cancer

    The future of prognostic factors in outcome prediction for patients with cancer di L P Fielding, Cecilia M. Fenoglio‐Preiser, Laurence S. Freedman

    Pubblicazione 1992
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential

    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential di S. Coverlizza, Mauro Risio, Andrea Ferrari, Cecilia M. Fenoglio‐Preiser, F. P. Rossini

    Pubblicazione 1989
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    American Joint Committee on Cancer prognostic factors consensus conference

    American Joint Committee on Cancer prognostic factors consensus conference di Carolyn C. Compton, Cecilia M. Fenoglio‐Preiser, Norman M. Pettigrew, L P Fielding

    Pubblicazione 2000
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Serrated Polyps of the Large Intestine

    Serrated Polyps of the Large Intestine di Dale C. Snover, Jeremy R. Jass, Cecilia M. Fenoglio‐Preiser, Kenneth P. Batts

    Pubblicazione 2005
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  5. 5
    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps

    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps di Won Chul Lee, Alfred I. Neugut, Gail Garbowski, Kenneth A. Forde, Michael R. Treat, J. Ways, Cecilia M. Fenoglio‐Preiser

    Pubblicazione 1993
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer di Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression

    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression di Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser, Monica P. Revelo-Penafiel, Sunil R. Hingorani, David A. Tuveson, Susan E. Waltz, Andrew M. Lowy

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 di Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Jiang Wang, Jacqueline Benedetti, Amanda F. Baker, Christopher B. Hackett, Susan G. Urba, Ken S. Zaner, Charles D. Blanke, James L. Abbruzzese

    Pubblicazione 2006
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation di Craig J. Burd, Christin E. Petre, Lisa M. Morey, Ying Wang, Mónica P. Revelo, Christopher A. Haiman, Shan Lu, Cecilia M. Fenoglio‐Preiser, Jiwen Li, Erik S. Knudsen, Jiemin Wong, Karen E. Knudsen

    Pubblicazione 2006
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S020... di Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O’Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, Saul E. Rivkin, Alok A. Khorana, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, James L. Abbruzzese, Charles D. Blanke

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: